The clinical effectiveness and cost-effectiveness of abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis: a systematic review and economic evaluation, Health Technology Assessment, Vol:20, Iss:34

Authors: Shepherd J, Cooper K, Harris P, Picot J, Rose M.
Source: NIHR Journals Library - Category: Global & Universal Source Type: research